Literature DB >> 14677330

Public health surveillance of diabetes in the United States.

Jay Desai1, Linda Geiss, Qaiser Mukhtar, Todd Harwell, Stephanie Benjamin, Ronny Bell, Ed Tierney.   

Abstract

The Centers for Disease Control and Prevention Division of Diabetes Translation supports a national and state surveillance system that analyzes, interprets, and reports on diabetes risk behaviors, risk factors, care practices, morbidity, and mortality. Data sources include surveys, the U.S. Renal Data System, the Indian Health Service, information on hospital inpatients, birth and death certificates, and special studies to use and to better understand the usefulness of data from managed care, Medicare, and Medicaid for monitoring diabetes. These data are used to define the magnitude and burden of diabetes; monitor changes in burden over time; guide public health planning and policy making, and assess progress toward diabetes objectives, such as those in Healthy People 2010. Challenges facing the diabetes surveillance system are limitations in data sources; the capture of undiagnosed diabetes; tracking key risk factors, such as levels of glycemia and lipids; and surveillance of high- or emerging-risk populations such as racial and ethnic groups, children and youth, and those with prediabetes. Limited resources, competing priorities, and issues of data privacy also challenge surveillance. To overcome these factors, the Division of Diabetes Translation strongly emphasizes partnering with other organizations, such as the Medicare and Medicaid programs, managed care, and other chronic disease programs.

Entities:  

Mesh:

Year:  2003        PMID: 14677330     DOI: 10.1097/00124784-200311001-00008

Source DB:  PubMed          Journal:  J Public Health Manag Pract        ISSN: 1078-4659


  13 in total

1.  The effectiveness and efficiency of diabetes screening in Ontario, Canada: a population-based cohort study.

Authors:  Sarah E Wilson; Laura C Rosella; Lorraine L Lipscombe; Douglas G Manuel
Journal:  BMC Public Health       Date:  2010-08-20       Impact factor: 3.295

2.  Where is obesity prevention on the map?: distribution and predictors of local health department prevention activities in relation to county-level obesity prevalence in the United States.

Authors:  Katherine A Stamatakis; Scott T Leatherdale; Christine M Marx; Yan Yan; Graham A Colditz; Ross C Brownson
Journal:  J Public Health Manag Pract       Date:  2012 Sep-Oct

3.  Who Must We Target Now to Minimize Future Cardiovascular Events and Total Mortality?: Lessons From the Surveillance, Prevention and Management of Diabetes Mellitus (SUPREME-DM) Cohort Study.

Authors:  Jay R Desai; Gabriela Vazquez-Benitez; Zhiyuan Xu; Emily B Schroeder; Andrew J Karter; John F Steiner; Gregory A Nichols; Kristi Reynolds; Stanley Xu; Katherine Newton; Ram D Pathak; Beth Waitzfelder; Jennifer Elston Lafata; Melissa G Butler; H Lester Kirchner; Abraham Thomas; Patrick J O'Connor
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-09

4.  State differences in the reporting of diabetes-related incorrect cause-of-death causal sequences on death certificates.

Authors:  Tain-Junn Cheng; Tsung-Hsueh Lu; Ichiro Kawachi
Journal:  Diabetes Care       Date:  2012-04-12       Impact factor: 19.112

5.  An innovative approach to enhancing the surveillance capacity of state-based diabetes prevention and control programs: the Diabetes Indicators and Data Sources Internet Tool (DIDIT).

Authors:  Qaiser Mukhtar; Erica R Brody; Prachi Mehta; Jenny Camponeschi; Cynthia K Clark; Jay Desai; Michael Friedrichs; Angela M Kemple; Heidi R Krapfl; Brenda Ralls; Jackson P Sekhobo
Journal:  Prev Chronic Dis       Date:  2005-06-15       Impact factor: 2.830

6.  Monitoring the occurrence of diabetes mellitus and its major complications: the combined use of different administrative databases.

Authors:  Stefano Brocco; Cristiana Visentin; Ugo Fedeli; Elena Schievano; Angelo Avogaro; Margherita Andretta; Francesco Avossa; Paolo Spolaore
Journal:  Cardiovasc Diabetol       Date:  2007-02-15       Impact factor: 9.951

7.  Program evaluation and chronic diseases: methods, approaches, and implications for public health.

Authors:  Leonard Jack; Qaiser Mukhtar; Maurice Martin; Mark Rivera; S René Lavinghouze; Jan Jernigan; Paul Z Siegel; Gregory Heath; Dara Murphy
Journal:  Prev Chronic Dis       Date:  2005-12-15       Impact factor: 2.830

8.  Evaluating progress toward Healthy People 2010 national diabetes objectives.

Authors:  Qaiser Mukhtar; Leonard Jack; Maurice Martin; Dara Murphy; Mark Rivera
Journal:  Prev Chronic Dis       Date:  2005-12-15       Impact factor: 2.830

9.  State-based diabetes surveillance among minority populations.

Authors:  Jay Desai
Journal:  Prev Chronic Dis       Date:  2004-03-15       Impact factor: 2.830

10.  Exploring the feasibility of combining chronic disease patient registry data to monitor the status of diabetes care.

Authors:  Angela M Kemple; Noelle Hartwick; Marilyn H Sitaker; Jeanne J Harmon; Kathleen Clark; Jan Norman
Journal:  Prev Chronic Dis       Date:  2008-09-15       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.